Invest now

Concord Biotech Cash Flow Annual

BSE: 543960 | NSE: CONCORDBIO | ISIN: INE338H01029 | Sector: Biotechnology & Drugs
1,353.35 -21.65 (-1.57%)Updated : 07 Aug 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Issuance( Retirement)of Debt Net -0.65-6.75-26.50-26.78
Net Changein Cash 11.28-14.2411.642.83
Cash Taxes Paid 100.41109.42103.3570.28
Net Income/ Starting Line 344.65494.55412.56322.01
Total Cash Dividends Paid -111.94-91.54-71.45-53.56
Changesin Working Capital -114.33-280.18-184.53-124.86
Cashfrom Operating Activities 266.88244.52265.47246.00
Cash Interest Paid 0.280.632.653.78
Cashfrom Financing Activities -112.88-98.77-99.21-85.22
Depreciation/ Depletion 74.4654.3753.5954.03
Other Investing Cash Flow Items Total -47.57-48.81-68.92-12.87
Capital Expenditures -95.15-111.17-85.69-145.08
period Type ----
Non- Cash Items -37.90-24.23-16.16-5.19
Financing Cash Flow Items -0.28-0.48-1.26-4.88
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -142.72-159.99-154.61-157.95
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,653.95+18.95(1.16%)
1,093.40-56.50 (-4.91%)
2,007.00-82.25 (-3.94%)